Life ScienceCompany
Transition Therapeutics Ownership
Who owns Transition Therapeutics?
Transition Therapeutics is owned by Opko Health. It was acquired on June 30, 2016.
Was Transition Therapeutics formerly PE-backed?
Yes. Transition Therapeutics was formerly owned by 1 private investor.
Transition Therapeutics Business Overview
Where is Transition Therapeutics headquartered?
Transition Therapeutics is headquartered in Toronto, Ontario.
How many employees does Transition Therapeutics have?
Transition Therapeutics has 18 employees.
What sector is Transition Therapeutics in?
Transition Therapeutics is a life science company.
When was Transition Therapeutics founded?
Transition Therapeutics was founded in 1987.
Life Science M&A Summary in 2016
Out of 60 sectors in the Mergr database, life science ranked 8 in number of deals in 2016. The largest life science acquisition in 2016 was Baxalta - which was acquired by Shire for $32.0B.
Join Mergr to view all 295 acquisitions of life science companies in 2016, including 33 acquisitions by private equity firms, and 262 by strategics.